|
The Oncology Institute Inc (NASDAQ: TOI) |
|
The Oncology Institute Inc
TOI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into The Oncology Institute Inc growth rates, revenue grew
by 21.78 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1416
Healthcare Facilities industry recorded
growth of revenues by 7.33 %
The Oncology Institute Inc net loss decreased from $-17 millions, to $-16 millions in III. Quarter 2024,
• More on TOI's Growth
|
|
The Oncology Institute Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1.41 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.07.
Healthcare Facilities industry's Price to Sales ratio is at 1.19.
• More on TOI's Valuation
|
|
|
|
|
The Oncology Institute Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1.41 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.07.
Healthcare Facilities industry's Price to Sales ratio is at 1.19.
The Oncology Institute Inc Price to Book Ratio is at 1.8 lower than Industry Avg. of 214.07. and higher than S&P 500 Avg. of 0.01
• More on TOI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com